Medicago inc.
$8,000,000.00 CAD
- Recipient country
- Canada
- Fiscal year
- 2015-2016
- Agreement period
- May 13, 2015 – December 31, 2021
- Reference
- ced-dec:093-2020-2021-Q1-00213
Published purpose
The project is part of an overall plan to build a complex combining the head office, R&D laboratories, a pilot plant and a commercial plant of a company specializing in the development and commercialization of vaccines and therapeutic proteins.
In plain English AI-generated
This contribution supports a project to build a complex in Quebec combining head office, R&D labs, pilot plant, and commercial plant for a company developing vaccines and therapeutic proteins.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.